https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announced-positive-topline-data-from-phase-ii-clinical-trial-of-lnk01001-in-the-treatment-of-atopic-dermatitis-301895890.html
/PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced positive...
phase iilynkpharmaceuticalsannouncedpositive
https://pubmed.ncbi.nlm.nih.gov/19841321/
The study did not meet its primary end point. However, the median PFS time of 4 months is promising. Pharmacogenetic studies in larger cohorts are needed to...
phase ii trialsecond linepemetrexedplusbevacizumab
https://www.advocate.com/health/health-news/2005/10/15/nih-launches-phase-ii-trial-hiv-vaccine
The National Institutes of Health this week launched a Phase II clinical trial of a vaccine aimed at preventing HIV infection, The Wall Street Journal reports....
phase ii trialhiv vaccinenihlaunchesadvocate
https://pubmed.ncbi.nlm.nih.gov/39983682/
The current recommendation for treating Lassa fever with ribavirin is supported only by weak evidence. Given the persistent effects in areas with endemic...
adaptive designphase iiplatform trialiiilassa
https://www.news-medical.net/news/20161007/Researchers-report-high-response-rate-with-single-drug-in-phase-III-trial-of-paediatric-brain-cancer.aspx
A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and...
response ratein phaseresearchersreporthigh
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2016-0514.html
This phase II trial studies how well brentuximab vedotin works in treating patients with CD30 positive (+) malignant mesothelioma that cannot be removed by...
phase ii trialbrentuximab vedotinadcetrismalignant
https://www.biospace.com/amgen-racks-up-success-in-phase-ii-lung-cancer-trial
Amgen announced data from the Phase II cohort of the CodeBreaK 100 trial of sotorasib (AMG 510) in 126 patients with KRAS G12C-mutated advanced non-small cell...
in phaselung canceramgenrackssuccess
https://www.barchart.com/story/news/36384078/new-data-from-the-phase-ii-archer-trial-demonstrate-cardiolrxtm-improves-heart-structure-in-patients-with-acute-myocarditis-supporting-expansion-across-inflammatory-cardiac-conditions
Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of...
from thephase iinewdataarcher
https://www.prnewswire.com/news-releases/blueberry-therapeutics-limited-announce-positive-results-from-a-phase-i-ii-clinical-trial-847837328.html
/PRNewswire/ -- Blueberry Therapeutics Limited ("Blueberry Therapeutics"), a modern drug discovery and development company committed to the development of...
phase iblueberrytherapeuticslimitedannounce
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02674
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients with Advanced Melanoma
phase iiiiitrialnivolumabipilimumab